Dry extracts of ginkgo leaves are considered promising drugs for improving age-related cognitive impairment. A study compared the phytochemical composition of fourteen medicines containing ginkgo that have been approved by German health authorities for this indication and revealed some considerable differences in the proportion of proanthocyanidins (PACs).
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- InFo NEUROLOGIE & PSYCHIATRIE
- PHYTOTHERAPIE PRAXIS
Related Topics
You May Also Like
- Dizziness as a leading symptom: new consensus paper
Current recommendations for handling in everyday practice
- Endometrial carcinoma, malignant melanoma and NSCLC in focus
Personalized mRNA and neoantigen vaccines in oncology
- Consequences for pathophysiology, clinic and therapy
The inflammatory subgroup of major depression
- Adherence of GLP1-RA
Half of patients discontinue treatment within a year
- RSV infection in adult patients at risk
Vaccination as a simple and sensible prophylaxis
- A case-based, practical overview from Canada
Vaccinations for heart patients
- Acne treatment: current trends
What role do dermocosmetics play?
- COPD: Tailor therapy to individual characteristics